(VIANEWS) – NORBIT (NORBT.OL), AKER SOLUTIONS (AKSO.OL), WDP (WDP.BR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NORBIT (NORBT.OL)
35% sales growth and 22.97% return on equity
Norbit ASA provides technology products and solutions. It operates through Oceans, Connectivity, and Product Innovation and Realization segments. The company offers multibeam sonar systems, including integrated bathymetric systems, bathymetry systems, advanced monitoring systems for dredging, construction and renewables, forward looking wide area imaging, advanced imaging systems for obstacle avoidance/MCM, and above water laser products under the NORBIT WINGHEAD, NORBIT WBMS, NORBIT NORdredge, and NORBIT FLS names; customized cable assemblies, electromechanical box builds, and operational solutions; SeaCOP, a sensor integration platform and user interface common operational picture for emergency response; SECurus provides thermal and daylight stabilized camera solutions; SeaView, which offers thermal and daylight, pan, tilt, and zoom for environmental monitoring, and security and general surveillance; and SeaDarQ, a radar processing solution. It also provides sensing solutions for detecting threats at sea plus waterside security above and below the surface; FCL600, an underwater light solution for aquaculture industry; iData, which offers vehicle monitoring, telematics services, and fleet management for asset and vehicle management; and dedicated short-range communication technology for traffic system and vehicle application. In addition, the company offers research and development services, and contract manufacturing to industrial customers; and sells products based on proprietary technology, including special instrumentation n based on radar, radio frequency, and embedded signal processing technology. Norbit ASA was founded in 1995 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, NORBIT has a trailing twelve months EPS of kr2.77.
PE Ratio
NORBIT has a trailing twelve months price to earnings ratio of 31.34. Meaning, the purchaser of the share is investing kr31.34 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 7, 2024, the estimated forward annual dividend rate is 2.55 and the estimated forward annual dividend yield is 2.8%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.3%, now sitting on 1.55B for the twelve trailing months.
More news about NORBIT.
2. AKER SOLUTIONS (AKSO.OL)
16.8% sales growth and 17.09% return on equity
Aker Solutions ASA provides solutions, products, systems, and services to the oil and gas industry in Norway, the United States, Brazil, the United Kingdom, Malaysia, Angola, Brunei, Canada, India, and internationally. The company operates in two segments, Renewables and Field Development; and Life Cycle. It offers field planning, feasibility, and concept studies; specialist engineering, project management, and procurement services; floater designs, offshore wind, as well as engages in design, delivery, and construction of oil and gas production, and receiving and processing facilities. The company also provides offshore fish farming, carbon capture, utilization and storage, hydrogen and derivatives, hydropower, and offshore wind solutions. Further, it designs and constructs jackets for construction services and offers electrification services; and designs and constructs offshore oil and gas production facilities and onshore receiving and processing facilities. Additionally, the company provides maintenance, modifications, decommissioning, asset integrity management, hook-up, and completion solutions. Aker Solutions ASA was founded in 1841 and is headquartered in Fornebu, Norway.
Earnings Per Share
As for profitability, AKER SOLUTIONS has a trailing twelve months EPS of kr3.06.
PE Ratio
AKER SOLUTIONS has a trailing twelve months price to earnings ratio of 13.92. Meaning, the purchaser of the share is investing kr13.92 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.09%.
Moving Average
AKER SOLUTIONS’s value is above its 50-day moving average of kr42.31 and above its 200-day moving average of kr39.19.
Revenue Growth
Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 48.05B for the twelve trailing months.
Volume
Today’s last reported volume for AKER SOLUTIONS is 195858 which is 64.37% below its average volume of 549835.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 14, 2023, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 2.01%.
More news about AKER SOLUTIONS.
3. WDP (WDP.BR)
12.5% sales growth and 4.89% return on equity
WDP develops and invests in logistics property (warehouses and offices). WDP has over 7 million m² of properties in its portfolio. This international portfolio of semi-industrial and logistics buildings is spread over about 300 sites at prime logistics hubs for storage and distribution in Belgium, France, the Netherlands, Luxembourg, Germany and Romania.
Earnings Per Share
As for profitability, WDP has a trailing twelve months EPS of €0.97.
PE Ratio
WDP has a trailing twelve months price to earnings ratio of 25.15. Meaning, the purchaser of the share is investing €25.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.89%.
Yearly Top and Bottom Value
WDP’s stock is valued at €24.40 at 17:20 EST, way below its 52-week high of €28.94 and way above its 52-week low of €22.16.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 437.19M for the twelve trailing months.
More news about WDP.
4. SANOFI (SAN.PA)
7.4% sales growth and 5.82% return on equity
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.5%, now sitting on 47.08B for the twelve trailing months.
Sales Growth
SANOFI’s sales growth for the next quarter is 7.4%.
Moving Average
SANOFI’s worth is below its 50-day moving average of €97.73 and under its 200-day moving average of €91.63.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 13, 2024, the estimated forward annual dividend rate is 3.76 and the estimated forward annual dividend yield is 3.64%.
More news about SANOFI.
